Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium.
Van Hauwermeiren F, Armaka M, Karagianni N, Kranidioti K, Vandenbroucke RE, Loges S, Van Roy M, Staelens J, Puimège L, Palagani A, Berghe WV, Victoratos P, Carmeliet P, Libert C, Kollias G.
Van Hauwermeiren F, et al. Among authors: kranidioti k.
J Clin Invest. 2013 Jun;123(6):2590-603. doi: 10.1172/JCI65624. Epub 2013 May 15.
J Clin Invest. 2013.
PMID: 23676465
Free PMC article.